Skip to main content
NXTC
NASDAQ Life Sciences

NextCure to Merge with Avere, Creating Once-Weekly Oral IL-23 Player

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.9
Mkt Cap
$7.874M
52W Low
$1.55
52W High
$15.74
52W Position info
87% above low
Off High info
82% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

NXTC sits 87% above its 52-week low of $1.55 on elevated volume (2.2× avg).

Summary

NextCure is merging with private biotech Avere Therapeutics in an all-stock transaction to advance a once-weekly oral IL-23 therapy. The combined company will operate as Avere Therapeutics, with NextCure shareholders owning roughly 25% and Avere shareholders 75%. The deal is expected to close in Q4 2026. Concurrently, NextCure announced a $320 million private investment from an investor syndicate. This follows NextCure's going concern warning and cash runway into H1 2027, providing a path forward for its pipeline. NextCure's recent positive Phase 1 data for SIM0505 adds to the combined entity's oncology assets.

At the time of this announcement, NXTC was trading at $2.90 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.9M. The 52-week trading range was $1.55 to $15.74. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

NXTC - Latest Insights

NXTC
Nov 10, 2026, 4:25 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $5.78
Real-time Price: $6.48 info
Change: +$0.700 (+12%) info
Market Cap: $30.679M info
NXTC
Nov 10, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.78
Real-time Price: $6.48 info
Change: +$0.700 (+12%) info
Market Cap: $30.679M info
NXTC
Nov 10, 2026, 4:05 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $5.78
Real-time Price: $6.48 info
Change: +$0.700 (+12%) info
Market Cap: $30.679M info
NXTC
Oct 30, 2026, 8:39 PM EDT
Filing Type: S-4/A
Importance Score:
8
Price at Filing: $6.31
Real-time Price: $6.48 info
Change: +$0.170 (+3%) info
Market Cap: $30.679M info
NXTC
Sep 30, 2026, 7:36 PM EDT
Filing Type: S-4/A
Importance Score:
9
Price at Filing: $5.01
Real-time Price: $6.48 info
Change: +$1.47 (+29%) info
Market Cap: $30.679M info